This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Daiichi Sankyo Company, Limited, Sankyo Company, Limited. Active years: 1993-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-2012
Title: Osamu Ando: Innovator in Medicinal Chemistry
Introduction
Osamu Ando is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target intracellular signal transduction.
Latest Patents
Ando holds 3 patents, with his latest inventions focusing on substituted cycloalkene derivatives. These compounds are designed to suppress intracellular signal transduction or cell activation induced by endotoxin. They aim to mitigate cell responses that lead to the excessive generation of inflammatory mediators, such as TNF-α. The medicaments developed from these compounds are intended for the prophylaxis and treatment of severe conditions like sepsis, septic shock, disseminated intravascular coagulation, and multiple organ failure.
Career Highlights
Throughout his career, Osamu Ando has worked with notable companies, including Daiichi Sankyo Company, Limited and Sankyo Company, Limited. His work has been instrumental in advancing therapeutic options for critical health issues.
Collaborations
Ando has collaborated with esteemed colleagues, including Tomio Kimura and Nobuyuki Ohkawa, contributing to the innovative research in his field.
Conclusion
Osamu Ando's work in medicinal chemistry exemplifies the impact of innovative inventions on healthcare. His contributions continue to pave the way for advancements in the treatment of serious medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile